WHO ICTRP trial
Safety, tolerability, pharmacokinetics, and pharmacodynamics of recombinant…
ChiCTR2100050044 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2100050044 |
|---|---|
| Public title | Safety, tolerability, pharmacokinetics, and pharmacodynamics of recombinant neorudin (yeast) for injection in the treatment of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) |
| Scientific title | Clinical study of recombinant neorudin (yeast) for injection |
| Primary sponsor | Fuwai Hospital, Chinese Academy of Medical Sciences |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | non-ST-segment elevation acute coronary syndrome (NSTE-ACS) |
| Interventions | test group:No |
| Registration date | Aug 16, 2021 |
| Target size | test group:24 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: